6 Results for "

U118-MG

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "U118-MG" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-14543
CAS No.: 106516-24-9
Purity:  99.92%
Synonyms: Lu 23-174
Sertindole (Lu 23-174) is an orally active 5-HT2A, 5-HT2C, dopamine D2, and αl-adrenergic receptors antagonist. Sertindole shows antipsychotic activity and anti-proliferative activity to multiple cancer cells .
loading...
    loading...
Cat. No.: HY-178969
Target:  

FAK Pyk2 Apoptosis

Research Areas:  

Neurological Disease Cancer

GZD-257 is a brain-penetrant, ATP-competitive FAK inhibitor (IC50 = 14.3 nM), performing 4.77-fold selectivity with FAK to Pyk2 (IC50 = 68.2 nM). GZD-257 can significantly induce apoptosis of U118MG cells and arrest the cell cycle at the G2/M phase. GZD-257 can be used for the study of Glioblastoma (GBM) .
loading...
    loading...
Cat. No.: HY-D2266
FluoBar1 is an imaging fluorescence probe modified by a barbiturate ligand with fluorescent coumarin. FluoBar1 can monitor L-type voltage-gated calcium channels (LTCC) in living cells in real time for the study of neurological diseases .
loading...
    loading...
Cat. No.: HY-14543R
CAS No.: 106516-24-9
Synonyms: Lu 23-174 (Standard)
Sertindole (Standard) is the analytical standard of Sertindole. This product is intended for research and analytical applications. Sertindole (Lu 23-174) is an orally active 5-HT2A, 5-HT2C, dopamine D2, and αl-adrenergic receptors antagonist. Sertindole shows antipsychotic activity and anti-proliferative activity to multiple cancer cells .
loading...
    loading...
Cat. No.: HY-187711
Target:  

FAK

Research Areas:  

Neurological Disease Cancer

FAK-IN-33 is a potent focal adhesion kinase (FAK) inhibitor with an IC50 value of 10.23 nM against FAK. FAK-IN-33 inhibits the viability of U118-MG glioblastoma cells with an IC50 of 0.29 μM, and shows low cytotoxicity toward LO2 and 2BS cells. FAK-IN-33 can be used in studies related to glioblastoma .
loading...
    loading...
Cat. No.: HY-183284
Target:  

FAK ERK Apoptosis

Research Areas:  

Neurological Disease Cancer

GZD-552 is a potent orally active FAK inhibitor with a human FAK IC50 of 5.8 nM. GZD-552 suppresses FAK phosphorylation activation and downstream ERK signaling. GZD-552 induces apoptosis and G2/M cell cycle arrest, and exhibits antiproliferative activities in glioblastoma multiforme cells. GZD-552 exhibits antitumor efficacy in mice xenograft model. GZD-552 can be used for the research of glioblastoma multiforme .
loading...
    loading...